Insulin resistance by homeostasis model assessment in HIV-infected patients on highly active antiretroviral therapy: cross-sectional study

[1] Triant VA(2008)Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies Lancet 372 293-9

[2] Lee H(2007)Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endocrinol Metab 92 2506-12

[3] Hadigan C(1998)Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1 infected patients AIDS 12 F167-73

[4] Grinspoon SK(2008)European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV HIV Med 9 72-81

[5] Walli R(2002)Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel J Acquir Immune Defic Syndr 31 257-75

[6] Herfort O(1985)Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412-9

[7] Michl GM(2002)Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 3143-421

[8] Demant T(2001)Determinant factors of the response insulinica in subjects with normal tests of oral tolerance to the glucose Acta Medica Peruana 18 12-7

[9] Jager H(2000)Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state Circulation 101 975-80

[10] Dieterle C(1999)Insulin resistance in HIV protease inhibitor-associated diabetes J Acquir Immune Defic Syndr 21 209-16

[1] Triant VA(2008)Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies Lancet 372 293-9

[2] Lee H(2007)Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endocrinol Metab 92 2506-12

[3] Hadigan C(1998)Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1 infected patients AIDS 12 F167-73

[4] Grinspoon SK(2008)European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV HIV Med 9 72-81

[5] Walli R(2002)Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel J Acquir Immune Defic Syndr 31 257-75

[6] Herfort O(1985)Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412-9

[7] Michl GM(2002)Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 3143-421

[8] Demant T(2001)Determinant factors of the response insulinica in subjects with normal tests of oral tolerance to the glucose Acta Medica Peruana 18 12-7

[9] Jager H(2000)Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state Circulation 101 975-80

[10] Dieterle C(1999)Insulin resistance in HIV protease inhibitor-associated diabetes J Acquir Immune Defic Syndr 21 209-16